Toll Free: 1-888-928-9744

Typhoid Fever - Pipeline Review, H2 2015

Published: Jul, 2015 | Pages: 49 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Typhoid Fever - Pipeline Review, H2 2015

Summary

Global Markets Direct's, 'Typhoid Fever - Pipeline Review, H2 2015', provides an overview of the Typhoid Fever's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Typhoid Fever, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Typhoid Fever and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Typhoid Fever
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved in the therapeutics development for Typhoid Fever and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects 
- A review of the Typhoid Fever products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Typhoid Fever pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Typhoid Fever
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Typhoid Fever pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Global Markets Direct Report Coverage 6 Typhoid Fever Overview 7 Therapeutics Development 8 Pipeline Products for Typhoid Fever - Overview 8 Pipeline Products for Typhoid Fever - Comparative Analysis 9 Typhoid Fever - Therapeutics under Development by Companies 10 Typhoid Fever - Therapeutics under Investigation by Universities/Institutes 11 Typhoid Fever - Pipeline Products Glance 12 Clinical Stage Products 12 Early Stage Products 13 Unknown Stage Products 14 Typhoid Fever - Products under Development by Companies 15 Typhoid Fever - Products under Investigation by Universities/Institutes 16 Typhoid Fever - Companies Involved in Therapeutics Development 17 Chongqing Zhifei Biological Products Co., Ltd. 17 GlaxoSmithKline Plc 18 Prokarium Limited 19 Protein Potential, LLC 20 Shantha Biotechnics Limited 21 USV Limited 22 Zydus Cadila Healthcare Limited 23 Typhoid Fever - Therapeutics Assessment 24 Assessment by Monotherapy Products 24 Assessment by Combination Products 25 Assessment by Target 26 Assessment by Route of Administration 28 Assessment by Molecule Type 29 Drug Profiles 31 (typhoid fever + shigellosis) multivalent vaccine - Drug Profile 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 Typhella - Drug Profile 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 Typhetec - Drug Profile 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 typhoid + paratyphoid (bivalent) vaccine - Drug Profile 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 typhoid + paratyphoid vaccine - Drug Profile 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 typhoid + pneumococcal vaccine - Drug Profile 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 typhoid and paratyphoid fever vaccine - Drug Profile 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 typhoid fever polysaccharide vaccine - Drug Profile 39 Product Description 39 Mechanism of Action 39 R&D Progress 39 typhoid vaccine - Drug Profile 40 Product Description 40 Mechanism of Action 40 R&D Progress 40 ViCRM-197 - Drug Profile 41 Product Description 41 Mechanism of Action 41 R&D Progress 41 Typhoid Fever - Recent Pipeline Updates 42 Typhoid Fever - Dormant Projects 43 Typhoid Fever - Discontinued Products 44 Typhoid Fever - Product Development Milestones 45 Featured News & Press Releases 45 Mar 11, 2013: Prokarium And University Of Birmingham Receive £0.4m Grant To Develop Next Generation Vaccines 45 Jun 05, 2008: Emergent BioSolutions Initiates U.S. Phase II Trial of Oral Typhoid Vaccine Candidate 45 Jan 08, 2008: Emergent BioSolutions Announces Final Phase II Clinical Study Results for Typhoid Vaccine 46 Nov 21, 2005: Emergent Biosolutions Starts Clinical Study Of Single-Dose Oral Typhoid Vaccine 46 Aug 30, 2005: Emergent Biosolutions' Typhoid Vaccine Achieves Positive Results In Phase II Clinical Study 46 Appendix 48 Methodology 48 Coverage 48 Secondary Research 48 Primary Research 48 Expert Panel Validation 48 Contact Us 48 Disclaimer 49
List of Tables
Number of Products under Development for Typhoid Fever, H2 2015 8 Number of Products under Development for Typhoid Fever - Comparative Analysis, H2 2015 9 Number of Products under Development by Companies, H2 2015 10 Number of Products under Investigation by Universities/Institutes, H2 2015 11 Comparative Analysis by Clinical Stage Development, H2 2015 12 Comparative Analysis by Early Stage Development, H2 2015 13 Comparative Analysis by Unknown Stage Development, H2 2015 14 Products under Development by Companies, H2 2015 15 Products under Investigation by Universities/Institutes, H2 2015 16 Typhoid Fever - Pipeline by Chongqing Zhifei Biological Products Co., Ltd., H2 2015 17 Typhoid Fever - Pipeline by GlaxoSmithKline Plc, H2 2015 18 Typhoid Fever - Pipeline by Prokarium Limited, H2 2015 19 Typhoid Fever - Pipeline by Protein Potential, LLC, H2 2015 20 Typhoid Fever - Pipeline by Shantha Biotechnics Limited, H2 2015 21 Typhoid Fever - Pipeline by USV Limited, H2 2015 22 Typhoid Fever - Pipeline by Zydus Cadila Healthcare Limited, H2 2015 23 Assessment by Monotherapy Products, H2 2015 24 Assessment by Combination Products, H2 2015 25 Number of Products by Stage and Target, H2 2015 27 Number of Products by Stage and Route of Administration, H2 2015 28 Number of Products by Stage and Molecule Type, H2 2015 30 Typhoid Fever Therapeutics - Recent Pipeline Updates, H2 2015 42 Typhoid Fever - Dormant Projects, H2 2015 43 Typhoid Fever - Discontinued Products, H2 2015 44



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $2000
Multi User - US $4000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify